Presentation at BioStock in Stockholm by CEO, Johan Olsson, Sensodetect AB (publ.)

SensoDetects CEO was invited to do a live presentation with Biostock and newsagency Direkt in Stockholm Sweden on the 27 November.

You can now watch the complete presentation and discussion via the News agency youtube link at (in English)

Also a video intervju in Swedish was done just after the presenation which can be found also at (in Swedish)

Both presentation and interview can also be found at Spotlight Stock Market 

Johan Olson

VD, SensoDetect Aktiebolag (publ)

Phone: +46 705 424600



SensoDetect highlights through patented equipment brain stem responses to audio stimuli in order to provide health care clear anomalies and patterns for use primarily within psychiatry. The goal is to increase efficiency in Psychiatry and thus the benefits for health care, society, patients and relatives.

Our Mission
Improve the lives of people with mental illness
Our Vision
Making ABR profiling tests with SensoDetect technology an integral part of setting diagnosis for mental illness
Our Value Proposition:
SensoDetect provides a complete audiogram for the brainstem, helping health care professional to set psychiatric diagnoses objectively and
cost effectively. This unique offering improves patients’ quality of life and reduces the economic impact on the health care system and society



Documents & Links